The Relationship between Self-Management and Glycemic Control in a Cohort of Children with Type 1 and Type 2 Diabetes

Luisa M Rodriguez1, Krishnavathana V Hassan1, Jeffrey Rhodes1

  • 1Department of Pediatric Endocrinology and Metabolism, Texas Children's Hospital, Baylor College of Medicine, USA.

Journal of Diabetes & Metabolism
|September 27, 2014
PubMed

Insights

A new clinic preparedness score tool showed that better self-management in type 1 diabetes (T1DM) correlates with improved glycemic control (HbA1C). This tool and its findings were less clear for type 2 diabetes (T2DM) in children.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Self-Management
  • Clinical Assessment Tools

Background:

  • Effective diabetes self-management is crucial for improving glycemic control.
  • Objective tools are needed in clinical settings to assess patient preparedness and adherence.
  • Existing methods may not fully capture the nuances of self-management across different diabetes types.

Purpose of the Study:

  • To develop and validate a clinic preparedness score for assessing diabetes self-management in pediatric patients.
  • To evaluate the correlation between clinic preparedness, adherence behaviors, and glycemic control (HbA1C) in type 1 diabetes (T1DM) and type 2 diabetes (T2DM).
  • To compare clinician perceptions of patient adherence with objective measures.

Main Methods:

  • A 23-question clinic preparedness tool was administered to 350 T1DM and 137 T2DM pediatric patients and their families.
  • HbA1C levels were correlated with parameters like glucose meter availability, hypoglycemia preparedness, and blood glucose logging.
  • Clinician perceptions of patient adherence and dose adjustments were also surveyed.

Main Results:

  • T1DM patients with higher clinic preparedness scores exhibited lower HbA1C levels (8.2% vs. 9.4%).
  • Parental involvement and insulin dose adjustments in T1DM were associated with better glycemic control.
  • Clinicians accurately predicted glycemic control based on reported dose adjustments, though similar correlations were not found for T2DM.

Conclusions:

  • Clinic preparedness appears to be a significant factor in achieving better glycemic control for pediatric T1DM.
  • Adherence measures and self-management characteristics differ between pediatric T1DM and T2DM.
  • Variability in glucose monitoring and medication administration may impact T2DM management distinctively compared to T1DM.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K